|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 901 New York Ave NW |
Address2 | Suite 515E |
City | Washington |
State | DC |
Zip Code | 20001-4432 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1967-12
|
||||||||
|
6. House ID# 317210000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jeanne Slade |
Date | 2/2/2024 4:27:59 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Opioids, pain management
Federal funding for Substance Use Disorder treatments
Reauthorization of Preventing Overdoses While in Emergency Rooms (POWER) program
H.R. 1359-Modernizing Opioid Treatment Access Act, to expand access to methadone for opioid use disorder treatment
H.R.5506-Hospitals as Naloxone Distribution Sites, to provide no-cost access to Naloxone at discharge for patients at risk for opioid overdose
H.R. 4531, Support for Patients and Communities Reauthorization Act, to reauthorize grants and programs to address opioid and substance use disorder
H.R.5506-Hospitals as Naloxone Distribution Sites, to provide no-cost access to Naloxone at discharge for patients at risk for opioid overdose
H.R.6600-Tylers Law, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement routine fentanyl testing for patients experiencing an overdose
S. 654-Modernizing Opioid Treatment Access Act, to expand access to methadone for opioid use disorder treatment
S. 3393- Support for Patients and Communities Reauthorization Act, to reauthorize grants and programs to address opioid and substance use disorder
S.3519-Tylers Law, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement routine fentanyl testing for patients experiencing an overdose
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Federal funding to implement Preventing Overdoses While in Emergency Rooms (POWER) program
Federal funding to implement MISSION ZERO program
Federal funding to for firearm safety and injury prevention research
Federal funding to implement Emergency Medical Services for Children (EMSC)
Federal funding for emergency medicine research activities
Federal funding for implementation of Dr. Lorna Breen Health Care Provider Protection Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DIS
16. Specific lobbying issues
Access to emergency medical supplies (including Personal Protective Equipment, COVID-19 tests, ventilators, and medications) during COVID-19 public health emergency
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA)
H.R. 4420, the Preparedness and Response Reauthorization Act
H.R. 4421, the Preparing for All Hazards and Pathogens Reauthorization Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy and Political Affairs
|
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R.1202-REDI Act, to amend the Higher Education Act of 1965 to provide for interest-free deferment on student loans for borrowers serving in a medical or dental internship or residency program.
S.704-REDI Act, to amend the Higher Education Act of 1965 to provide for interest-free deferment on student loans for borrowers serving in a medical or dental internship or residency program
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Advocacy |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Federal funding for firearms safety and injury prevention research
Firearms safety and injury prevention policy
H.R. 715-Bipartisan Background Checks Act of 2023
H.R.5010-Recognizing Gun Violence as a Public Health Emergency Act, to provide an annual report on the public health impacts of firearms violence
S. 494-Background Check Expansion Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Reproductive health, physician-patient relationship, and EMTALA issues
Emergency department boarding
Drug shortages
Health care consolidation
H.R.1694-Emergency Care Improvement Act, to permanently allow for coverage under Medicare and Medicaid of services that are provided by freestanding emergency centers.
H.R.2412-Helping Kids Cope Act, to provide grants to improve mental health access for children and reduce pediatric emergency department boarding
H.R. 2416-To reauthorize the MISSION ZERO military-civilian partnership for trauma readiness
H.R. 2940-PASTEUR Act of 2023, to incentivize new antimicrobial development
H.R.4941-Providing Access to Treatment and Housing Act
H.R 5414-Improving Mental Health Access from the Emergency Department Act
H.R.5804-Mental Health Infrastructure Improvement Act of 2023, to provide loans and grants to improve mental health treatment and substance use disorder treatment facilities
S. 1346-Improving Mental Health Access from the Emergency Department Act
S. 1355- PASTEUR Act of 2023, to incentivize new antimicrobial development
S. 1447-Bipartisan Solution to Cyclical Violence Act of 2023, to establish a grant program to support trauma center violence intervention and violence prevention programs
S. 2586-Drug Shortages Prevention and Quality Improvement Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
No Surprises Act implementation
Eliminating prior authorization requirements in Medicare Advantage
H.R. 4968-GOLD CARD Act of 2023, to improve prior authorization processes under Medicare Advantage for physicians with high approval rates
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Workplace violence prevention for health care workers
H.R. 731-Workforce Mobility Act of 2023, to prohibit the use of noncompete agreements
H.R. 2574-EMS Counts Act, to ensure more accurate counts of trained EMS personnel by Bureau of Labor Statistics
H.R. 2663-Workplace Violence Prevention for Health Care and Social Service Workers Act, to require OSHA to issue workplace violence prevention standards to protect health care and social service workers
S. 220-Workforce Mobility Act of 2023, to prohibit the use of noncompete agreements
S. 1115-EMS Counts Act, to ensure more accurate counts of trained EMS personnel by Bureau of Labor Statistics
S. 1176-Workplace Violence Prevention for Health Care and Social Service Workers Act, to require OSHA to issue workplace violence prevention standards to protect health care and social service workers
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Federal funding for emergency medicine research activities
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Physician payment reform
Counting observation stays as satisfying Medicare three-day inpatient stay prerequisite for skilled nursing facility (SNF) coverage
Eliminating prior authorization requirements in Medicare Advantage
H.R. 1128-Rural Health Care Access Act of 2023, to eliminate the 35-mile requirement to qualify as a critical access hospital
H.R. 1129-Rural ER Access Act, to require the Centers for Medicare and Medicaid Services to repeal the 35-mile requirement for off-campus facilities
H.R. 2474-Strengthening Medicare for Patients and Providers Act, to add an inflationary adjustment to physician payments under the Medicare Physician Fee Schedule
H.R. 4968-GOLD CARD Act of 2023, to improve prior authorization processes under Medicare Advantage for physicians with high approval rates
H.R. 5213-Reducing Medically Unnecessary Delays in Care Act of 2023, to ensure that prior authorization medical decisions under Medicare are determined by physicians
H.R. 6371-Provider Reimbursement Stability Act, to reform the Medicare budget neutrality process
H.R. 6545-Physician Fee Schedule Update and Improvements Act, to provide a 1.25 percent adjustment to the 2024 Medicare Physician Fee Schedule conversion factor and update the budget neutrality threshold
H.R. 6683-Preserving Seniors Access to Physicians Act of 2023, to fully eliminate the 3.37 percent conversion factor adjustment for calendar year 2024
S. 3430-Better Mental Health Care, Lower-Cost Drugs and Extenders Act, to provide a 1.25 percent adjustment to the 2024 Medicare Physician Fee Schedule conversion factor, and other provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Fentanyl analogues scheduling extension
H.R. 2584-Safety from Violence for Healthcare Employees (SAVE) Act, to establish federal criminal penalties for violence against health care workers
S.1080-Cooper Davis Act
S.2484-Expanding Nationwide Access to Test Strips Act, to ensure states do not prohibit individuals from possessing or obtaining fentanyl test strips
S.2644-American Law Enforcement SAVER Act, to provide standards for trauma kits purchased using Byrne JAG grant funds
S.2768-Safety from Violence for Healthcare Employees (SAVE) Act, to establish federal criminal penalties for violence against health care workers
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AVI
16. Specific lobbying issues
Updating first aid and emergency medical kits and flight crew training requirements
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy and Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |